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The Wnt1-Cre transgenic mouse line is extensively used in the study of the development of the neural
crest and its derivatives and the midbrain. The Wnt1 gene has important developmental roles in
formation of the midbrain–hindbrain boundary, regulation of midbrain size, and neurogenesis of ventral
midbrain dopaminergic (mDA) neurons. Here, we report that Wnt1-Cre transgenic mice exhibit
phenotypes in multiple aspects of midbrain development. Signiﬁcant expansion of the midbrain and
increased proliferation in the developing inferior colliculus is associated with ectopic expression ofWnt1.
Marked elevation of Wnt1 expression in the ventral midbrain is correlated with disruption of the
differentiation program of ventral mDA neurons. We ﬁnd that these phenotypes can be attributed to
ectopic expression of Wnt1 from the Wnt1-Cre transgene leading to the ectopic activation of canonical
Wnt/β-catenin signaling. Since these caveats could complicate the utility of Wnt1-Cre in some
developmental circumstances, we report a new Wnt1-Cre2 transgenic mouse line that can serve the
same purposes as the original without the associated phenotypic complications. These studies reveal an
important caveat to a widely-used reagent, provide an improved version of this reagent, and indicate that
the original Wnt1-Cre transgenic mouse line may be useful as a gain of function model for interrogating
Wnt signaling mechanisms in multiple aspects of midbrain development.
& 2013 Elsevier Inc. All rights reserved.Introduction
The Wnt1-Cre mouse transgenic line is widely used for inter-
rogating gene function and cell lineage relationships in a variety of
developmental contexts including early neural crest migration,
secondary palate, calvaria, cardiac outﬂow tract, and midbrain
development (Brewer et al., 2004; Chai et al., 2000; Ito et al., 2003;
Jiang et al., 2000, 2002; Katayama et al., 2011; Merrill et al., 2006;
Tallquist and Soriano, 2003; Yoshida et al., 2008). Its utility is
based on the fact that the Wnt1 gene is highly expressed in the
dorsal neural tube prior to the emigration of the neural crest and
in the midbrain–hindbrain boundary (MHB) at the initiation of
midbrain development. The Wnt1-Cre line, in combination with
various Cre reporters, has thus been heavily employed for lineage
tracing studies of neural crest cells and the midbrain.
Wnt1 has multiple roles in midbrain development. Inactivation
of the Wnt1 gene in mice resulted in loss of the entire mid/ll rights reserved.
d Tissue Biology, Program in
for Human Genetics, Univer-
4143, United States.hindbrain region (McMahon and Bradley, 1990; Thomas and
Capecchi, 1990). Ectopic expression of Wnt1 throughout the CNS
under the control of the HoxB4 enhancer dramatically increased
mitogenesis without altering patterning (Dickinson et al., 1994).
Further, when Wnt1 was ectopically expressed under the control
of the endogenous engrailed1 promoter in En1Wnt1 mice, pattern
formation in the MHB was maintained, but increased proliferation
and drastic overgrowth of the caudal-dorsal midbrain were
observed (Panhuysen et al., 2004).
Ventral midbrain dopaminergic (mDA) neurons develop in
close proximity to the MHB, a source of Wnt1 expression, and
ultimately modulate a broad range of neural processes, including
movement, cognition and reward; their dysfunction leads to
severe neurological disorders such as Parkinson's disease (PD).
Therefore, understanding the molecular control of mDA differen-
tiation is critical in the ultimate goal of therapeutic mDA neuron
production, engraftment and function. The mDA differentiation
program can be divided into three distinct steps (Prakash and
Wurst, 2006b). First, induction of a progenitor ﬁeld within the
neuroepithelium that is competent to generate mDA precursors
occurs between E8.5–E10.5 in the mouse and is characterized by
the expression of general proneural genes such as the Ngn2
A.E. Lewis et al. / Developmental Biology 379 (2013) 229–234230transcription factor. Second, the speciﬁcation of postmitotic mDA
precursors marked by expression of markers such as the nuclear
receptor family member Nurr1 occurs at E10.5–E12.5. Finally,
terminal differentiation begins by E12.5 and is characterized by
the expression of tyrosine hydroxylase (TH), the rate-limiting
enzyme in DA synthesis (Prakash and Wurst, 2006a, 2006b).
Wnt signaling has been shown to have critical roles in the second
and third steps of mDA neurogenesis, but has not been implicated
in the ﬁrst (Prakash et al., 2006; Tang et al., 2009). It is clear that
Wnt1 is involved in establishment of the committed mDA pro-
genitor domain because ectopic Wnt1 expression in the ventralhindbrain induced ectopic mDA neurons and because its expres-
sion was necessary for ectopic induction of mDA neurons by Fgf8
and Shh in ventral forebrain explants (Prakash et al., 2006). Loss of
the obligate downstream Wnt signaling mediator β-catenin within
the ventral midbrain in Shh-Cre; β-cateninﬂ/ﬂ embryos led to a
dramatic reduction in mDA neurogenesis without changes in
ventral midbrain patterning, whereas the later loss of β-catenin
in differentiating mDA neurons revealed a role in the ﬁnal step of
mDA differentiation (Tang et al., 2009). Interestingly, hyperactiva-
tion of the pathway within the ventral midbrain in Shh-Cre;
β-cateninEx3 embryos resulted in a loss of mDA neurons, possibly
by preventing cell cycle exit and differentiation of Ngn2-
expressing committed progenitors to postmitotic progenitors
(Tang et al., 2010). In these embryos, the induction of an mDA-
competent progenitor ﬁeld occurred and expression of Ngn2 and
Nurr1 were slightly expanded. Taken together, these studies
established the importance of Wnt signaling during midbrain
development. During our studies of gene function in neural crest,
we discovered that midbrain development is perturbed by the
Wnt1-Cre transgene; since this transgene is so widely used, we
investigated these phenotypes in greater depth.Materials and methods
Genotyping
DNA was isolated from either tail or embryonic yolk sac
samples, depending upon embryonic stage. qPCR was performed
for the Wnt1-Cre transgene using primers in the second and third
introns of Wnt1 to determine quantity of transgene relative to the
wild-type locus: 5′-CCA-CCT-CTT-CGG-CAA-GAT-CG-3′ forward and
5′-GCT-AGA-AAG-AAT-CTG-GTG-CTG-ACC-3′ reverse. This geno-
typing was conducted using Bambi as a reference gene for copy
number.
Histology, immunoﬂuorescence and in situ hybridization
Embryos for histology were ﬁxed in Bouin's ﬁxative, dehydrated
through graded ethanol concentrations and embedded in parafﬁn.
Sections were subsequently cut at 7 μm thickness and stained with
hematoxylin and eosin. Embryos for immunoﬂuorescence and in situ
hybridization were ﬁxed in 4% PFA, dehydrated to 25% sucrose and
embedded in OCT; sections were cut at a thickness of 12 μm.
Immunostaining was performed according to standard protocols using
antibodies recognizing tyrosine hydroxylase (1:250; Millipore cat#
AB152), BrdU (1:200; Abcam AB6326), Lef1 (1:75; Cell SignalingFig. 1. Wnt1 misexpression activates ectopic canonical Wnt/β-catenin signaling and
disrupts midbrain development in Wnt1-Cre transgenic mice. (A–C) Whole mount view
of P0 brains reveals slightly expanded midbrain in Wnt1-CreTg/+ mice (B) and drama-
tically expanded midbrain in Wnt1-CreTg/Tg mice (C) compared with wild-type (A). (D–F)
Histological coronal sections of E18.5 mouse brains show dramatic expansion of the
midbrain inWnt1-CreTg/+mice (E) and more severe expansion inWnt1-CreTg/Tg mice (F).
This expansion mostly affects the inferior colliculus and is accompanied by its thinning
and increased nuclear density (arrowhead in F). (G–I) Whole mount in-situ hybridization
of E12.5 embryos reveals punctate misexpression ofWnt1 around the caudolateral edge
of the midbrain–hindbrain boundary in Wnt1-CreTg/+ (arrows in H) and Wnt1-CreTg/Tg
embryos (arrows in I) compared with wild-type (G) (J–L) In situ hybridization of E12.5
coronal sections reveals ectopic Wnt1 expression in the caudolateral aspect of the
mesencephalon in Wnt1-CreTg/+ embryos (K), with increased intensity and extent in
Wnt1-CreTg/Tg embryos (L) (inset boxes in J–L). The expression of Wnt1 in the dorsal
aspect of the midbrain is also increased in intensity at these stages (arrowheads, J–L).
(M–U) In situ hybridization of sections adjacent to J–L reveals Cre expression (M–O),
Axin2 upregulation (P–R), and Lef1 upregulation (S–U) in the caudolateral aspect of the
mesencephalon of Wnt1-CreTg/+(N,Q,T) and Wnt1-CreTg/Tg (O,R,U) embryos in regions
corresponding to those with ectopic expression of Wnt1. Scale bars: (A–C) 2mm, (D–F)
1 mm, (G–U) 500 mm. (SC) superior colliculus, (IC) inferior colliculus, (Aq) aqueduct, (Cb)
cerebellum, (4 V) fourth ventricle, (BS) brain stem.
A.E. Lewis et al. / Developmental Biology 379 (2013) 229–234 231Technology product# 2230), and CyclinD1 (1:200; ThermoScientiﬁc
cat# RB-010-P*). For BrdU experiments, pregnant dams were injected
with 50 μg BrdU per gram body weight at 20 or 30 min prior to
euthanasia for E12.5 or E15.5 embryos, respectively. In situ hybridiza-
tion was performed according to standard protocols. In situ hybridized
slides were counterstained with Orange G (Fig. 3; Supplementary
Fig. 3; Supplementary Fig. 4I–K) or Nuclear Fast Red (Supplementary
Fig. 1). TheWnt1 in situ probe hybridizes to base pairs 437–852 on the
Wnt1mRNA (RefSeq NM_021279), corresponding to the entire second
exon and roughly 60% of the third exon.
RT-PCR, qRT-PCR and western blots
Total RNA was extracted from snap frozen E12.5 and E13.5
embryos, according to Invitrogen's TRIzol Reagent protocol. cDNA
was synthesized using Invitrogen's First-Strand Synthesis kit usingFig. 2. Molecular basis for ectopic Wnt1 expression in Wnt1-CreTg embryos. (A) Schema
transcripts. A Wnt1-Cre chimeric transcript carrying the complete Cre open reading fram
encode the entireWnt1 transcript plus 165 5′ base-pairs derived from the LacZ sequence.
reading frame. (B) Quantitative RT-PCR using primers recognizing all three Wnt1 tran
embryonic Wnt1-CreTg heads. Quantitative RT-PCR using primers recognizing only the w
between genotypes (e1e2 in A). Error bars represent standard deviation from qRT-PCR pe
E14.5 embryonic head extracts reveals a 1.5-fold upregulation of Wnt1 protein in Wnt1
Wnt1-CreTg/Tg embryos. Non-muscle myosin heavy chain IIA was used as a loading contrandom hexamers to prime the reverse transcriptase. Wnt1-Cre
transcript sequencing was performed on RT-PCR products obtained
using the following primer sets: Wnt1 5′utr 5′-CTC-ATT-GTC-TGT-
GGC-CCT-GAC-C-3′ forward with Cre 5′-ACG-CCT-GGC-GAT-CCC-TGA-
AC-3′ reverse, and Cre 5′-CGC-TGG-AGT-TTC-AAT-ACC-GG-3′ forward
with Wnt1 exon 3 5′-CGG-AGG-TGA-TTG-CGA-AGA-TG-3′ reverse.
Wnt1-Gal4 transcript sequencing was performed on RT-PCR products
obtained according to the above scheme, replacing Cre primers with
the following Gal4 primers: 5′-GTC-GGC-AAA-TAT-CGC-ATG-CTT-G-3′
reverse and 5′-TTC-AAA-ACC-ACT-GTC-ACC-TGG-3′ forward. Expres-
sion analysis of total Wnt1 was carried out by qRT-PCR with Wnt1
primers in the third and fourth exons (e3e4): 5′-CAT-CTT-CGC-
AAT-CAC-CTC-CG-3′ forward and 5′-GTG-GCA-TTT-GCA-CTC-TTG-
G-3′ reverse. Endogenous Wnt1 expression was quantiﬁed using a
Wnt1 primer pair in the ﬁrst and second exons (e1e2): 5′-ACA-
GTC-GTC-AGA-ACC-GCA-GC-3′ forward and 5′-TCA-ACA-GGT-TCG-tic representation of wild-type Wnt1 transcript and two Wnt1-CreTg-speciﬁc Wnt1
e, followed by part of the LacZ gene, also has an open reading frame predicted to
TheWnt1-Gal4 chimeric transcript is not predicted to encode a completeWnt1 open
scripts (e3e4 in A) indicates variable overexpression of Wnt1 transcript in E13.5
ild-type Wnt1 transcript indicate that endogenous Wnt1 expression remains similar
rformed on individual embryos in triplicate. (C) Western blot analysis of Wnt1 from
-CreTg/+ embryos, and an approximately 2.3-fold upregulation of Wnt1 protein in
rol, and error bars represent standard error.
A.E. Lewis et al. / Developmental Biology 379 (2013) 229–234232TGG-AGG-AGG-C-3′ reverse. These experiments were conducted using
GAPDH as a reference gene. For protein quantiﬁcation, E14.5 heads
were homogenized in NP40 buffer and subjected to 10% SDS-PAGE and
western blotting according to standard techniques. Blots were probed
with Wnt1 (Abcam cat# ab15251) and non-muscle myosin heavy
chain IIA (Covance cat# PRB-440) antibodies and analyzed using an
ImageQuant LAS 4000 scanner and software (GE).
Generation of Wnt1-Cre2 transgenic mice
Wnt1 promoter and enhancer sequences were isolated from the
pWEXP3C plasmid (Danielian and McMahon, 1996). The 1.3 kb
Wnt1 5′ promoter sequence was isolated by digestion with NotI
and EcoRV from the pWEXP3C plasmid and placed upstream of a
cDNA encoding Cre recombinase, followed by a 5.5 kb BglII frag-
ment that includes the Wnt1 3′ enhancer. Transgenic lines were
backcrossed to 129S4 mice and examined for Cre activity by
crossing to ROSA26R reporter mice (Soriano, 1999). Allele speciﬁc
genotyping of Wnt1-Cre2 transgenic mice was performed by PCR
with primers (5′-ACA-GCG-AAC-CAT-GCT-GCC-TG-3′) and (5′-CAT-
GTC-CAT-CAG-GTT-CTT-GC-3′) giving a 465 bp product. The Wnt1-
Cre2 mice (129S4-Tg(Wnt1-cre)1Sor/J) are being deposited to the
Jackson Laboratory Mouse Repository and will be available under
Stock# 22137.Results and discussion
Abnormal Wnt1 expression and its phenotypic consequences in
Wnt1-Cre mice
Over the course of our studies, we came to appreciate that Wnt1-
CreTg/+ embryos display a marked enlargement of the midbrain
beginning at E11.5, concomitant with dilation of the midbrain aque-
duct (Fig. 1A–F). At E15.5, the inferior colliculi were thin and expanded,
with increased CyclinD1 expression and overt cell proliferation as
measured by BrdU incorporation, phenotypes that were exacerbated
in Wnt1-CreTg/Tg brains (Supplementary Fig. 1A–C,G–I). Moreover, atFig. 3. Elevated Wnt1 expression in the ventral midbrain disrupts the mDA differentiat
reveals a dramatic elevation in Wnt1 expression in the ventral midbrain region of Wnt1
sections adjacent to A–F with an antibody to tyrosine hydroxylase (TH) reveals a nearly
wild-type (I). Dramatically reduced TH staining is observed in E13.5 Wnt1-CreTg/Tg embry
A–F reveals the absence of expression of Ngn2 within the Wnt1 misexpression domain
E12.5, reduced Ngn2 expression is observed within this domain in Wnt1-CreTg/Tg embryos
have recovered at E13.5 (Q,R). In situ hybridization of sections adjacent to A–F reveals a co
E11.5 (S,T) and E12.5 (U,V). Nearly complete recovery of Nurr1 expression is observed aE12.5, Wnt1-CreTg/+ embryos also displayed a reduction in TH-
expressing mDA neurons, which were nearly completely absent from
Wnt1-CreTg/Tg embryos (Supplementary Fig. 2A–C). These phenotypes
were completely penetrant and consistent in Wnt1-Cre mice obtained
directly from Dr. A.P. McMahon or from the Jackson Laboratories (Tg
(Wnt1-cre)11Rth Tg(Wnt1-GAL4)11Rth/J), on 129S4 and C57Bl/6J
backgrounds.
To understand the basis for these phenotypes, we examined
Wnt1 expression by in-situ hybridization and found that at E12.5,
Wnt1 consistently exhibited elevated expression in the dorsal
neural tube and ectopic expression in the caudolateral neuroecto-
derm of the mesencephalon (Fig. 1G–L). In addition, Wnt1 exhib-
ited expanded expression in more rostral sections of the ventral
midbrain, adjacent to regions with altered TH staining (Fig. 3A–F;
Supplementary Fig. 2D–F). Furthermore, the pattern of misexpres-
sion ofWnt1 was identical to that of the Cre transcript inWnt1-Cre
embryos and correlated with the positions of midbrain expansion
and mDA neuron loss (Fig. 1M–O; Supplementary Fig. 2A–C). These
results indicate that Wnt1-Cre transgenic mice exhibit ectopic
upregulation of Wnt1 that correlates with the midbrain pheno-
types that we observe.Ectopic expression of Wnt1 from the Wnt1-Cre transgene
The Wnt1-Cre transgene was generated by inserting a Cre
recombinase cDNA between a 1.3 kb upstream element including
the promoter and the Wnt1 coding sequence, destroying the Wnt1
initiation ATG in the process. This was followed by a 5.5 kb
downstream genomic sequence that carries Wnt1 enhancer
elements (Danielian et al., 1998). This transgene was co-injected with
aWnt1-Gal4 transgene constructed using a similar strategy (http://
jaxmice.jax.org/strain/003829.html). To determine the basis for
the misexpression of full length Wnt1, we performed a series of
RT-PCR sequence experiments, identifying two transgene-speciﬁc
species of Wnt1 transcript in Wnt1-CreTg embryos (Fig. 2A). The
ﬁrst of these included the 5′ UTR of Wnt1 followed by Cre and
the 3′ part of exon 1 spliced normally to the remaining 3′ exons.ion program. (A–F) In situ hybridization of coronal sections of the ventral midbrain
-CreTg/Tg embryos (B,D,F) compared with wild-type (A,C,E). (G–L) Immunostaining of
complete absence of mDA neurons in E12.5 Wnt1-CreTg/Tg embryos (J) compared to
os (L) compared to wild-type (K). (M–R) In situ hybridization of sections adjacent to
in E11.5 Wnt1-CreTg/Tg embryos (arrowheads in B,N) compared to wild-type (M). At
(arrowheads in P) compared to wild-type (O), whereas Ngn2 expression appears to
mplete loss of Nurr1 expression in Wnt1-CreTg/Tg embryos compared to wild-type at
t E13.5 (W,X). Scale bars: 200 mm.
A.E. Lewis et al. / Developmental Biology 379 (2013) 229–234 233Although the Wnt1 ATG initiator codon was mutated to ATC, we
found an in-frame ATG located in the vector sequence 165 bp
upstream of the usual Wnt1 start codon. This reading frame is
predicted to encode a protein with 55 additional N-terminal amino
acids, which would be cleaved as part of the signal sequence.
A second transgene-speciﬁc transcript instead incorporated the
Gal4 gene sequence into the ﬁrst exon of Wnt1 but did not possess
an in-frame ATG that could explain Wnt1 expression.
Using quantitative RT-PCR, we found that total Wnt1 transcript
was between 10.3 and 67.4 fold more abundant in E14.5 Wnt1-
CreTg/+ embryonic heads and 84.5 fold more abundant in Wnt1-
CreTg/Tg than in controls (Fig. 2B). To test whether this transgene
might also be affecting expression of the endogenous Wnt1 locus,
we performed quantitative RT-PCR to differentiate between endo-
genous Wnt1 transcript and total transcript and found that
endogenous Wnt1 transcript remained similar to wild-type levels
in Wnt1-CreTg embryos. Western blot analysis of E14.5 embryonic
head lysates conﬁrmed an increase in Wnt1 protein correlating
with genotype (Fig. 2C). Since Wnt1 is typically an activator of
canonical Wnt/β-catenin signaling, we examined the expression of
the downstream transcriptional targets Axin2 and Lef1; these two
genes were also upregulated in the regions of ectopic Wnt1
upregulation (Fig. 1P–U; Supplementary Fig. 1D–I; Supplementary
Fig. 2G–I). Taken together, these results indicate that ectopic Wnt1
expressed from theWnt1-Cre transgene activates canonical Wnt/β-
catenin signaling, possibly leading to the midbrain phenotypes
that we observe.Fig. 4. The new Wnt1-Cre2 transgenic mouse line mediates recombination in the
neural crest. (A) Schematic representation of the new Wnt1-Cre2 transgenic
construct. (B–I) β-galactosidase staining of Wnt1-CreTg/+; ROSA26R+/− embryos from
the original line (B,D,F,H) compared with newly generated Wnt1-Cre2Tg/+;
ROSA26R+/− transgenic mice (C,E,G,I), in which the Wnt1 coding sequence is not
included in the transgene, at progressive stages of development. Comparable
staining is observed in the neuroepithelium and migrating neural crest of E8.5
embryos in Wnt1-Cre2Tg/+; ROSA26R+/− (C) compared to the original Wnt1-CreTg/+;
ROSA26R+/− (B). No overt difference was seen at E9.5 (D,E) or E10.5 (F,G), or in
whole mount β-galactosidase staining of hearts at P1 (H,I).Ectopic Wnt signaling perturbs the ﬁrst step of the mDA
differentiation program
To begin to determine the developmental mechanisms by
which elevated Wnt1 expression in the ventral midbrain (vMb)
disrupts mDA neurogenesis, we examined expression of key
markers in a developmental sequence from E11.5 to E13.5. At each
of these stages, dramatically elevated Wnt1 expression was
observed in the vMb of Wnt1-CreTg/Tg embryos, correlating with
loss of TH-expressing mDA neurons (Fig. 3A–L) and increased cell
proliferation in the vMb of E12.5 Wnt1-CreTg/Tg embryos (Supple-
mentary Fig. 3D–F). Examination of the generic proneural marker
Ngn2 revealed a striking loss of expression in Wnt1-CreTg/Tg at
E11.5, speciﬁcally within the domain of Wnt1 overexpression
(Fig. 3B,N). Whereas the domain of Ngn2 expression was still
perturbed within the domain of Wnt1 overexpression at E12.5,
nearly complete recovery of expression was observed at E13.5, at
which point a few TH-positive mDA neurons had also formed
(Fig. 3O–R). The expression of Nurr1, a marker of postmitotic mDA
progenitors and a gene necessary for the expression of TH in
mature mDA neurons (Prakash and Wurst, 2006b), was completely
absent from the vMb at E11.5 and dramatically reduced in E12.5
Wnt1-CreTg/Tg embryos compared with control (Fig. 3S–V).
Again, recovery of Nurr1 expression was observed by E13.5,
when some TH-expressing neurons were apparent (Fig. 3W–X).
Taken together, these results provide evidence that elevated Wnt/
β-catenin signaling in the vMb of Wnt1-CreTg/Tg embryos causes
extended maintenance of a proliferative, mDA-incompetent domain.
This idea is consistent with ﬁndings that treatment of rat ventral
midbrain precursor cultures with Wnt1-conditioned media
increased the total number of neurons by affecting proliferation
and not the proportion of TH-positive cells (Castelo-Branco et al.,
2003). Our results suggest that Wnt/β-catenin signaling levels
must be tightly controlled to allow the correct initiation of an
mDA-competent precursor domain in the vMb and indicate that
the Wnt1-CreTg/Tg mouse line may be a useful tool in the detailed
study of this process.Generation and characterization of a new Wnt1-Cre transgenic
mouse
Because the Wnt1-Cre transgene has been so transformative for
studies of neural crest and midbrain development, we adapted the
original strategy for the generation of this transgene to generate a
newWnt1-Cre2 transgenic mouse line (129S4-Tg(Wnt1-cre)1Sor/J)
that would avoid the complications of ectopic Wnt1 expression.
This line includes the same 1.3 kb 5′ promoter sequence, Cre, and a
5.5 kb 3′ enhancer sequence without the Wnt1 gene sequence
A.E. Lewis et al. / Developmental Biology 379 (2013) 229–234234itself. This transgene is similar to a transgenic line that has been
previously shown to exhibit Wnt1-restricted LacZ reporter activity
(Echelard et al., 1994). We screened founders by PCR and veriﬁed
insertion of the Wnt1-Cre2 transgene in four of these lines by
Southern blot (data not shown). Crossing these new Wnt1-Cre2
founders with ROSA26R Cre reporter mice indicated that these
transgenic lines recapitulate Cre recombinase activity in both the
cardiac and cranial neural crest (Fig. 4; Supplementary Fig. 4C–F).
More detailed characterization of one of these lines revealed
similar recombination patterns to the original Wnt1-Cre in the
branchial arches and cardiac outﬂow tract (Fig. 4B–I; Supplemen-
tary Fig. 4C–F), two tissues with well-characterized neural crest
contributions. Although some recombination was also detected in
branchial arch and frontonasal epithelium of Wnt1-Cre2; ROSA26R+/−
embryos, closer examination revealed similar epithelial activity of
the originalWnt1-Cre transgenic line (Supplementary Fig. 4A–B). This
pattern of staining has been found to be reproducible over four
backcross generations to 129S4, indicating that expression of Cre is
stable in this transgenic line. Importantly, the Wnt1-Cre2 line does
not exhibit the ectopic Wnt1 expression or midbrain enlargement
(Supplementary Fig. 4I–K) present in the original Wnt1-Cre trans-
genic mouse. Taken together, these observations indicate that the
Wnt1-Cre2 line will be a suitable replacement to achieve deletion in
the neural crest cell lineages.Conclusion
The generation of the Wnt1-Cre transgene was pioneering, and
its broad application in midbrain and neural crest studies has
transformed multiple ﬁelds of developmental biology. As such, it is
critical to note the caveat of ectopic activation of Wnt/β-catenin
signaling that we describe here. These phenotypes are consistent
with known roles for Wnt/β-catenin signaling in these contexts
and indicate that ectopic activation of Wnt/β-catenin signaling
may pose a confounding factor for some studies involving this
mouse line (Dickinson et al., 1994; Panhuysen et al., 2004; Prakash
et al., 2006; Tang et al., 2009, 2010). The Wnt1-Cre line may
continue to prove useful in contexts that have been veriﬁed to lack
ectopic activation of Wnt/β-catenin signaling. This promoter con-
struct has also been used to drive the expression of other genes
during midbrain development (Danielian and McMahon, 1996; Lee
et al., 1997); we have no information on whether those studies
would be inﬂuenced by the ﬁndings presented here. Finally, the
effect of misexpression ofWnt1 on mDA neurons may makeWnt1-
Cre transgenic mice a useful model for studying the differentiation
of mDA neurons with the purpose of designing restorative thera-
pies for Parkinson's disease.Acknowledgments
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